Skip to content
Disclosery

LYNCH & ASSOCIATES/IN: EMR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of LYNCH & ASSOCIATES/IN on EMR, newest first. How the timeline and the estimate are built.

LYNCH & ASSOCIATES/IN held 72,473 EMR shares at 2026-06-30 per its 13F-HR filed 2026-07-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 72,473 shares
    Change vs previous 13F -348 shares

    1.81% of the 13F portfolio, value $10,374,485.

    13F-HR 0001108965-26-000003 filed by LYNCH & ASSOCIATES/IN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 72,821 shares
    Change vs previous 13F -893 shares

    1.79% of the 13F portfolio, value $9,540,985.

    13F-HR 0001108965-26-000002 filed by LYNCH & ASSOCIATES/IN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 73,714 shares
    Change vs previous 13F -1,116 shares

    1.85% of the 13F portfolio, value $9,783,299.

    13F-HR 0001108965-26-000001 filed by LYNCH & ASSOCIATES/IN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 74,830 shares
    Change vs previous 13F -1,403 shares

    1.9% of the 13F portfolio, value $9,816,263.

    13F-HR 0001108965-25-000006 filed by LYNCH & ASSOCIATES/IN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 76,233 shares
    Change vs previous 13F -417 shares

    2.05% of the 13F portfolio, value $10,164,211.

    13F-HR 0001108965-25-000005 filed by LYNCH & ASSOCIATES/IN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 76,650 shares
    Change vs previous 13F -511 shares

    1.82% of the 13F portfolio, value $8,403,959.

    13F-HR 0001108965-25-000004 filed by LYNCH & ASSOCIATES/IN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 77,161 shares
    Change vs previous 13F -2,675 shares

    2.07% of the 13F portfolio, value $9,562,561.

    13F-HR 0001108965-25-000001 filed by LYNCH & ASSOCIATES/IN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 79,836 shares
    Change vs previous 13F not available

    1.85% of the 13F portfolio, value $8,731,700.

    13F-HR 0001108965-24-000004 filed by LYNCH & ASSOCIATES/IN
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).